Rise of Generics and Patent Expirations Sees CPhI and P-MEC India 2013 Expand
Rise of Generics and Patent Expirations Sees CPhI and P-MEC India 2013 Expand
PR55190
AMSTERDAM, Dec. 2 /PRN=KYODO JBN/ --
CPhI announces that CPhI and P-MEC India, run by leading events organiser
UBM, is returning to the Bombay Convention and Exhibition Centre, Mumbai
(India) from the 3rd to the 5th December 2013. The event will return with an
increased scale, continuing its commitment to cater to all sectors of the
pharma industry by co-locating with ICSE and BioPh India.
(Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )
With a view to enhancing the customer experience and ROI value, CPhI India
has enhanced the mobile application, now available on all mobile devices with
an internet connection, designed to help attendees navigate their way around
the event, drive traffic to stands and stay up to date with schedules and
speaker events.
With the addition of hall 7, P-MEC will host even more exhibitors than
previous years. Last year, there were 926 exhibitors present and this is
expected to rise to 1,000 this year to create the biggest show to date. Free
online registration to attend CPhI and P-MEC India is now closed, however
registration is still possible in Mumbai, the onsite fee is only INR500.
India has increasingly become a focal point of the pharmaceutical industry
and is now the third largest in terms of volume. The country is fast becoming
an innovation hub, increasingly matching Western standards, whilst also
reducing the costs of manufacturing, showcasing the Indian pharma markets
unique position and providing an optimum investment platform for international
companies. Outside of the US, India has the highest number of FDA approved
facilities (546), and the Indian pharma sector received USFDA approvals for
around 40% of all Abbreviated New Drug Approvals (ANDA) during January-July
2013. Further, with R&D investments rapidly advancing, coupled with the rise in
generics and supergenerics, India represents a key maturing market, with CPhI
and P-MEC India facilitating opportunities to drive and enhance the sector.
Ahead of the event, the UBM India pharma awards will take place on 2nd
December, celebrating the most innovative and dynamic areas across the Indian
pharma community. Honouring companies who are driving forward industry changing
initiatives, there will be awards for multiple categories including 'Excellence
in Product Development', 'Excellence in Contract Research' and 'Excellence in
Packaging Development'. The evening will also host a panel discussion on
'Moving up the Global Pharma Value Chain', designed to inform and educate those
present at the awards ceremony.
"The global pharmaceutical market has seen a significant shift over the
last year, particularly as patent expirations are becoming more frequent and a
potential patent cliff is shaking the industry. India, however, is thriving as
the demand for generics is on the rise and companies are looking to drive down
manufacturing costs. India is well positioned to accommodate increased demand,
providing expertise in development and manufacturing. CPhI and P-MECIndia will
provide the ideal and essential platform for international and domestic
suppliers and buyers to break into the market." - Chris Kilbee, Group Director,
Pharma.
Notes to editors
About CPhI
CPhI drives growth and innovation at every step of the global
pharmaceutical supply chain from drug discovery to finished dosage. Through
exhibitions, conferences and online communities, CPhI brings together more than
100,000 pharmaceutical professionals each year to network, identify business
opportunities and expand the global market. CPhI hosts events in Europe, China,
India, Japan, Southeast Asia, Russia and South America co-located with ICSE for
contract services, P-MEC for machinery, equipment & technology, InnoPack for
pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer
& supplier directory at CPhI-Online.com and hosts a global community with news
and analysis at PharmaEvolution.com.
For more information visit: http://www.cphi.com
The UBM Live annual schedule of Pharmaceutical events also includes CPhI,
ICSE, P-MEC, BioPh and Pharmatec Japan (9-11 April, 2014 in Tokyo); CPhI Russia
and IPhEB (16-17 April, 2014 in St Petersburg, Russia); CPhI, P-MEC and
Innopack South East Asia (20-22 May, 2014 in Jakarta, Indonesia); CPhI Istanbul
(4-6 June, 2014, Turkey) and CPhI, Hi and Fi, ICSE, P-MEC, BioPh and LabWorld
China (26-28 June, 2014 at SNIEC, Shanghai, China), CPhI South America (5-7
August 2014 at Expo Centre Norte, Sao Paulo- Brazil); CPhI Worldwide, ICSE,
P-MEC Europe and InnoPack (7-9 October, 2013 at Nord Ville Pinte Paris, France)
For media enquiries, please contact:
Alex Heeley or Tristan Jervis
De Facto Communications
T: +44(0)207-203-6745
E: a.heeley@defacto.com, t.jervis@defacto.com
Source: UBM Live
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。